Follow the HLS Therapeutics Inc. stock price and the full management transaction log of the company, a listed equity based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. Market capitalisation: €114.5m. The latest transaction was filed on 28 August 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: HLS Therapeutics Inc.. All data is accessible without an account.
68
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HLS Therapeutics Inc. Strong Buy (bullish), based on 4 analysts. Average price target: CA$7.32.
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,817 of 29,056 companies
45.1
score / 100
Value
53
Quality
38
FCF yld13%
Earn yld-11%
EV/EBITDA10.4x
ROE-14%
Gross mgn82%
Net mgn-22%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
HLS Therapeutics Inc. es una empresa farmacéutica canadiense centrada en el desarrollo y la comercialización de tratamientos para enfermedades crónicas. Cotiza en la Bolsa de Toronto bajo el símbolo HLS.